Depression (Treatment-Resistant) Clinical Trials

A listing of Depression (Treatment-Resistant) medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

University of Alabama at Birmingham
Birmingham Alabama 35294

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Arkansas

APC Clinical Research Trials, PA
Little Rock Arkansas 72211

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

California

CI Trials
Bellflower California 90706

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

SPRI Clinical Trials LLC
Lemon Grove California 91945

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A 12-week, randomized, double-blind, controlled evaluation followed by an open-label 12-week follow-up period of the impact of GeneSight Psychotropic on response to psychotropic treatment in outpatients suffering from a major depressive disorder (MDD) and having had- with the current episode- an inadequate response to at east one psychotropic medication included in GeneSight Psychotropic.

Pacific Research Partners
Oakland California 94607

Clinical trial testing new treatment for people with depression

Syrentis Clinical Research
Santa Ana California 92705

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Schuster Medical Research Institute
Sherman Oaks California 91403

DEPRESSED: Tried Treatment WITHOUT Results

CNS Network, LLC
Torrance California 90502

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Florida

Georgia

Emory University
Atlanta Georgia 30329

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Atlanta Center for Medical Research
Atlanta Georgia 30331

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

NEW

Atlanta Center for Medical Research
ATLANTA Georgia 30331

Depression Study for ages 18 to 65.

iResearch Atlanta
Decatur Georgia 30030

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Illinois

AMITA Health
Arlington Heights Illinois 60005

A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Subjects with Treatment-resistant Depression

Louisiana

Lake Charles Clinical Trials
Lake Charles Louisiana 70629

A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression (SUSTAIN-1)

Lake Charles Clinical Trials
Lake Charles Louisiana 70629

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Maryland

Pharmasite Research Inc.
Baltimore Maryland 21208

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Missouri

Washington University in St. Louis - Center for Clinical Studies
St. Louis Missouri 63110

A Washington University research study seeks participants with treatment-resistant bipolar depressive disorder.

New Hampshire

Geisel School of Medicine at Dartmouth Dartmouth Hitchcock Medical Center
Lebanon New Hampshire 03756

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

New York

SPRI CLINICAL TRIALS BROOKLYN
Brooklyn New York 11235

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

SPRI Clinical Trials LLC
Brooklyn New York 11235

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Mood and Anxiety Disorders Program at the Icahn School of Medicine at Mount Sinai
New York New York 10029

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Ohio

Department of Psychiatry, Ohio State University
Columbus Ohio 43210

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Oklahoma

IPS Research
Oklahoma City Oklahoma 73103

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Texas

Baylor College of Medicine
Houston Texas 77030

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Research Across America (Synexus US)
Plano Texas 75093

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Utah

PRA Health Sciences
Salt Lake City Utah 84107

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

PRAHS
Salt Lake City Utah 84106

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Washington

Northwest Clinical Research Center
Bellevue Washington 98007

A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder

Northwest Clinical Research Center
Bellevue Washington 98007

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Canada

Chatham-Kent Clinical Trials Research Centre
Chatham International N7L 1C1

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

Chokka Center for Integrative Health
Edmonton International T6L 6W6

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

McMaster University/MacAnxiety Research Centre
Hamilton International L8S 1B7

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

START Clinic for Mood and Anxiety Disorders
Toronto International M4W 2N4

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder